We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

LXEH:NASDAQLixiang Education Holding Co., Ltd. Analysis

Data as of 2026-06-20 - not real-time

$1.22

Latest Price

9/10Risk

Risk Level: High

Executive Summary

LXEH trades at $1.22, hovering just above its recent support of $1.07. The 20‑day SMA (1.42) sits modestly above the 50‑day SMA (1.38), suggesting a short‑term technical edge. However, both averages are dramatically lower than the 200‑day SMA (5.32), underscoring a long‑term downtrend. The 14‑day RSI at 41 indicates the stock is neither overbought nor oversold, leaving room for movement. MACD signals are bearish, with the line below the signal and a negative histogram, reinforcing downside pressure. Volume trends are increasing, hinting that market participants are paying attention despite the weak price action. The company recently regained Nasdaq compliance on the minimum bid price, a material positive catalyst.
On the fundamentals side, revenue fell 11.6% year‑over‑year and gross margin is a deep‑negative 38.7%, reflecting an unprofitable core business. Operating margin sits at –138% and cash flow is heavily negative, while debt towers at $133 M against a market cap of just $2.3 M. The stock has suffered a staggering 97% max drawdown and exhibits extreme 30‑day volatility of roughly 95%. A beta of –0.67 suggests the share moves opposite to the market, adding to its unpredictable profile. Combined, these metrics paint a picture of a severely distressed, highly speculative equity.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Bearish MACD histogram
  • Extreme short‑term volatility
  • Negative operating cash flow

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Regained Nasdaq compliance
  • Deep discount to book value
  • Uncertainty around Chinese education regulations

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Sustained high debt load
  • Persistently negative margins
  • High regulatory and sector risk in China

Key Metrics & Analysis

Financial Health

Revenue Growth-11.60%
ROE-81.19%
ROA-5.78%
Debt/Equity86.76
P/B Ratio0.1
Op. Cash Flow$-314302880
Free Cash Flow$-10815052

Technical Analysis

TrendNeutral
RSI41.5
Support$1.07
Resistance$2.45
MA 20$1.42
MA 50$1.38
MA 200$5.32
MACDBearish
VolumeIncreasing
Fear & Greed Index91.46

Valuation

GradeUndervalued
TypeValue

Risk Assessment

Beta-0.67
Volatility94.87%
Sector RiskMedium
Reg. RiskHigh
Geo RiskMedium
Currency RiskLow
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.